We are live on
!
Find out more
RSVP
Ramsay Stattman Vela & Price Portfolio holdings
AUM
$506M
1-Year Est. Return
14.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.25%
1 Year Est. Return
+14.19%
3 Year Est. Return
+54.61%
5 Year Est. Return
+69.05%
10 Year Est. Return
+247.84%
AUM
$173M
AUM Growth
+$12M
(+7.4%)
Cap. Flow
+$4.06M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
36.79%
Holding
52
New
2
Increased
26
Reduced
13
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$3.31M |
| 2 |
AT&T
T
|
+$1.14M |
| 3 |
Abbott
ABT
|
+$640K |
| 4 |
CERN
Cerner Corp
CERN
|
+$195K |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$101K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$1.45M |
| 2 |
AbbVie
ABBV
|
+$312K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$161K |
| 4 |
Automatic Data Processing
ADP
|
+$107K |
| 5 |
Johnson & Johnson
JNJ
|
+$64.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 21.49% |
| 2 | Healthcare | 16.04% |
| 3 | Industrials | 12.52% |
| 4 | Technology | 9.47% |
| 5 | Energy | 8.4% |
Similar funds
WWG
RFG
BA
KHLMTHM
WMG
MCM
OWP
CBTWT
Ramsay Stattman Vela & Price's Q3 2013 Portfolio in Review
As of Q3 2013, Ramsay Stattman Vela & Price held 52 positions worth $173M, up 7.4% from $161M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ramsay Stattman Vela & Price's Q3 2013 filing shows 2 new, 26 increased, 13 reduced and 2 closed positions. Its largest new stake was Qualcomm: 50,455 shares worth $3.4M. The largest sale was Teva Pharmaceuticals, an estimated $1.45M.
By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.
- Ramsay Stattman Vela & Price's largest Q3 2013 buy was Qualcomm: 50,455 shares worth $3.4M.
- Ramsay Stattman Vela & Price added most to AT&T in Q3 2013, an estimated $1.14M increase.
- Ramsay Stattman Vela & Price's biggest Q3 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $161K.
- Ramsay Stattman Vela & Price fully exited Teva Pharmaceuticals in Q3 2013, selling an estimated $1.45M.
- Ramsay Stattman Vela & Price's ten largest holdings make up 37% of its $173M portfolio in Q3 2013.
- Ramsay Stattman Vela & Price opened 2 new positions and closed 2 in Q3 2013.
- Ramsay Stattman Vela & Price's portfolio value rose 7.4% quarter-over-quarter to $173M.
Based on Ramsay Stattman Vela & Price's 13F filing for Q3 2013, filed 12 Nov 2013.